{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "64842-0120",
      "generic_name": "FUTIBATINIB",
      "labeler_name": "TAIHO PHARMACEUTICAL CO., LTD.",
      "brand_name": "LYTGOBI",
      "active_ingredients": [
        {
          "name": "FUTIBATINIB",
          "strength": "4 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "64842-0120-4",
          "description": "1 BLISTER PACK in 1 CARTON (64842-0120-4)  / 21 TABLET in 1 BLISTER PACK",
          "marketing_start_date": "20230203",
          "sample": false
        },
        {
          "package_ndc": "64842-0120-5",
          "description": "1 BLISTER PACK in 1 CARTON (64842-0120-5)  / 28 TABLET in 1 BLISTER PACK",
          "marketing_start_date": "20230203",
          "sample": false
        },
        {
          "package_ndc": "64842-0120-6",
          "description": "1 BLISTER PACK in 1 CARTON (64842-0120-6)  / 35 TABLET in 1 BLISTER PACK",
          "marketing_start_date": "20230203",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "TAIHO PHARMACEUTICAL CO., LTD."
        ],
        "rxcui": [
          "2628195",
          "2628201",
          "2628203",
          "2628204",
          "2628205",
          "2628206",
          "2628207",
          "2628208",
          "2721464",
          "2721466",
          "2721467",
          "2721468",
          "2721469",
          "2721470"
        ],
        "spl_set_id": [
          "0b1332a1-0581-4707-9bf6-1eccfa39bef4"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175605",
          "N0000194026",
          "N0000185503",
          "N0000190113"
        ],
        "pharm_class_epc": [
          "Kinase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Fibroblast Growth Factor Receptor Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]"
        ],
        "unii": [
          "4B93MGE4AL"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET",
      "spl_id": "87b2e0c4-3351-4a85-b721-19a0574daafa",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20230203",
      "product_id": "64842-0120_87b2e0c4-3351-4a85-b721-19a0574daafa",
      "application_number": "NDA214801",
      "brand_name_base": "LYTGOBI",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Fibroblast Growth Factor Receptor Inhibitors [MoA]",
        "Kinase Inhibitor [EPC]",
        "P-Glycoprotein Inhibitors [MoA]"
      ]
    }
  ]
}